Inactivation Of Cbl-b Can Obviate The Requirement For CD28 Costimulation Of T Cells In Tumor Rejection
Technology
E-153-2009
Patent ID
E-153-2009-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
60/844,240
IC
NCI
Date Filed
Date Issued
Patent PDF